The role of clinical phenotypes in decisions to limit life-sustaining treatment for very old patients in the ICU

Abstract

Background Limiting life-sustaining treatment (LST) in the intensive care unit (ICU) by withholding or withdrawing interventional therapies is considered appropriate if there is no expectation of beneficial outcome. Prognostication for very old patients is challenging due to the substantial biological and functional heterogeneity in that group. We have previously identified seven phenotypes in that cohort with distinct patterns of acute and geriatric characteristics. This study investigates the relationship between these phenotypes and decisions to limit LST in the ICU. Methods This study is a post hoc analysis of the prospective observational VIP2 study in patients aged 80 years or older admitted to ICUs in 22 countries. The VIP2 study documented demographic, acute and geriatric characteristics as well as organ support and decisions to limit LST in the ICU. Phenotypes were identified by clustering analysis of admission characteristics. Patients who were assigned to one of seven phenotypes (n = 1268) were analysed with regard to limitations of LST. Results The incidence of decisions to withhold or withdraw LST was 26.5% and 8.1%, respectively. The two phenotypes describing patients with prominent geriatric features and a phenotype representing the oldest old patients with low severity of the critical condition had the largest odds for withholding decisions. The discriminatory performance of logistic regression models in predicting limitations of LST after admission to the ICU was the best after combining phenotype, ventilatory support and country as independent variables. Conclusions Clinical phenotypes on ICU admission predict limitations of LST in the context of cultural norms (country). These findings can guide further research into biases and preferences involved in the decision-making about LST. Trial registration Clinical Trials NCT03370692 registered on 12 December 2017.

Clinical Characteristics and Prognosis of Older Patients with Coronavirus Disease 2019 Requiring Mechanical Ventilation

“…While the restricted use of these aggressive therapies in geriatric patients reflects the careful clinical judgment of the potential risks and benefits, specific studies linking age to limited COVID-19 therapies are scarce [ 19 , 20 ]. Previous studies have shown that an advanced age is often associated with decisions to limit life-sustaining treatment [ 21 , 22 ], suggesting that similar considerations may influence less aggressive treatment approaches for geriatric patients with COVID-19. These associations underscore the need for nuanced clinical decision making that takes into account the unique complexities of treating critical illness in the older population.…”

Frailty assessment in critically ill older adults: a narrative review

“…An assessment of the CFS by two different specialists when possible (for example, a geriatrician and an intensivist) is advisable, especially when the CFS is used as a triage tool among others. The identification of phenotypes with specific geriatric and acute characteristics, found to be associated with ICU mortality, may help move past an evaluation based only on the CFS [ 74 ].…”

The critically ill older patient with sepsis: a narrative review

“…Decisions to limit life-sustaining treatment (LST) should account for baseline status, quality of life, survival potential, functional outcomes, and treatment burden. Mousai et al [ 140 ] illustrate that integrating clinical phenotypes with cultural factors and information about critical care course enhances predictive discrimination accuracy for LST in very old ICU patients. Clinicians can make these decisions either before ICU admission or as the patient’s condition evolves.…”